Capital Stage Stock Price, News & Analysis (ETR:CAP)

€7.00 +0.04 (+0.57 %)
(As of 02/21/2018 02:02 PM ET)
Previous Close€7.00
Today's Range€6.89 - €7.00
52-Week Range€5.85 - €7.15
Volume199,043 shs
Average Volume252,359 shs
Market Capitalization$892.64 million
P/E Ratio30.43
Dividend Yield2.87%
BetaN/A

About Capital Stage (ETR:CAP)

Capital Stage logoCapital Stage AG is a principal investment firm specializing in acquisition and operation of solar and onshore-wind energy and parks. It does not focus on investing in Greenfield projects from scratch or take significant development or construction risk. It invests in Germany, France, and Italy. The firm typically invests up to ?5 million ($6.62 million) and ?20 million ($26.50 million) in "key ready" parks/plants. It seeks to exit its investments between five years and seven years via IPO, trade sales, secondary purchases, or buy-backs. The firm seeks to acquire a majority stake and invests out of its balance sheet. It focuses on acquiring and operating turnkey solar and wind parks from the secondary market. The firm may invest as a co-investor. Capital Stage AG was formed in 1996 and is based in Hamburg, Germany.

Receive CAP News and Ratings via Email

Sign-up to receive the latest news and ratings for CAP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolETR:CAP
CUSIPN/A
Phone+49-40-3785620

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E Ratio30.4347826086957
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPS€0.23
Net IncomeN/A
Net Margins22.43%
Return on Equity8.67%
Return on Assets2.41%

Miscellaneous

EmployeesN/A
Outstanding Shares128,250,000

Capital Stage (ETR:CAP) Frequently Asked Questions

What is Capital Stage's stock symbol?

Capital Stage trades on the ETR under the ticker symbol "CAP."

Where is Capital Stage's stock going? Where will Capital Stage's stock price be in 2018?

5 Wall Street analysts have issued 12-month price objectives for Capital Stage's shares. Their predictions range from €7.15 to €8.50. On average, they anticipate Capital Stage's share price to reach €7.99 in the next year. View Analyst Ratings for Capital Stage.

Who are some of Capital Stage's key competitors?

Who are Capital Stage's key executives?

Capital Stage's management team includes the folowing people:

  • Manfred Krueper, Chairman of the Supervisory Board
  • Dierk Paskert, Chairman of the Management Board, Chief Executive Officer (Age 56)
  • Alexander Stuhlmann, Vice Chairman of the Supervisory Board (Age 69)
  • Christoph Husmann, Chief Financial Officer, Member of the Management Board (Age 50)
  • Holger Goetze, Chief Operating Officer, Member of the Management Board (Age 48)
  • Albert Buell, Member of the Supervisory Board
  • Peter Heidecker, Member of the Supervisory Board (Age 59)
  • Joern Kreke, Member of the Supervisory Board
  • Cornelius Liedtke, Member of the Supervisory Board
  • Klaus-Dieter Maubach, Member of the Supervisory Board (Age 55)

What is Capital Stage's stock price today?

One share of Capital Stage stock can currently be purchased for approximately €7.00.

How big of a company is Capital Stage?

Capital Stage has a market capitalization of $892.64 million.

How can I contact Capital Stage?

Capital Stage's mailing address is Grosse Elbstrasse 59, HAMBURG, 22767, Germany. The company can be reached via phone at +49-40-3785620.


MarketBeat Community Rating for Capital Stage (CAP)

Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  99 (Vote Outperform)
Underperform Votes:  53 (Vote Underperform)
Total Votes:  152
MarketBeat's community ratings are surveys of what our community members think about Capital Stage and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Capital Stage (ETR:CAP) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: €7.99€7.99€7.99€8.27

Capital Stage (ETR:CAP) Consensus Price Target History

Price Target History for Capital Stage (ETR:CAP)

Capital Stage (ETR:CAP) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
1/17/2018DZ BankReiterated RatingBuyView Rating Details
1/1/2018Baader BankSet Price TargetBuy€7.80View Rating Details
11/21/2017Warburg ResearchSet Price TargetBuy€8.50View Rating Details
9/13/2017Berenberg BankSet Price TargetBuy€8.50View Rating Details
9/4/2017Oddo BhfSet Price TargetBuy€7.15View Rating Details
(Data available from 2/21/2016 forward)

Earnings

Earnings History for Capital Stage (ETR:CAP)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Capital Stage (ETR:CAP) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Capital Stage (ETR:CAP)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Capital Stage (ETR CAP)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Capital Stage (ETR CAP) News Headlines

Source:
DateHeadline
SparkLabs Cultiv8 Launches Its 1st Batch with AgTech, FoodTech and Sustainability Startups from Across the Globe - BenzingaSparkLabs Cultiv8 Launches Its 1st Batch with AgTech, FoodTech and Sustainability Startups from Across the Globe - Benzinga
www.benzinga.com - February 17 at 7:16 AM
Addex Launches CHF40 million Capital Increase with Commitment from Specialist US Healthcare InvestorsAddex Launches CHF40 million Capital Increase with Commitment from Specialist US Healthcare Investors
www.benzinga.com - February 16 at 7:16 AM
Canopy Launches Canopy Ventures I, a $50 Million Venture Fund Targeting Growth Stage Companies Supporting the Legal Cannabis IndustryCanopy Launches Canopy Ventures I, a $50 Million Venture Fund Targeting Growth Stage Companies Supporting the Legal Cannabis Industry
www.bizjournals.com - February 1 at 8:03 AM
European stocks edge higher as earnings takes center stage; ECB decision loomsEuropean stocks edge higher as earnings takes center stage; ECB decision looms
www.cnbc.com - January 25 at 8:03 AM
ERI Co-Founder Kevin Dillon and Li Tong Group Share the Stage for Panel on Data Security and Reverse Management Solutions at IERC 2018ERI Co-Founder Kevin Dillon and Li Tong Group Share the Stage for Panel on Data Security and Reverse Management Solutions at IERC 2018
www.businesswire.com - January 18 at 5:44 PM
Capital Stage (CAP) Earns "Buy" Rating from DZ BankCapital Stage (CAP) Earns "Buy" Rating from DZ Bank
www.americanbankingnews.com - January 17 at 11:26 AM
Renault-Nissan Starts Up $1 Billion Venture Fund for Car TechnologyRenault-Nissan Starts Up $1 Billion Venture Fund for Car Technology
www.msn.com - January 10 at 5:58 PM
Meet The Man Who Steers Lewis Hamilton To VictoryMeet The Man Who Steers Lewis Hamilton To Victory
www.forbes.com - January 8 at 11:51 AM
Capital Stage (CAP) Given a €7.80 Price Target by Baader Bank AnalystsCapital Stage (CAP) Given a €7.80 Price Target by Baader Bank Analysts
www.americanbankingnews.com - January 1 at 7:18 AM
Baader Bank Reiterates €7.80 Price Target for Capital Stage (CAP)Baader Bank Reiterates €7.80 Price Target for Capital Stage (CAP)
www.americanbankingnews.com - December 25 at 6:30 AM
Novartis (NVS) Oncology Head Strigini to Step Down by Dec. 31Novartis (NVS) Oncology Head Strigini to Step Down by Dec. 31
www.zacks.com - December 18 at 6:01 PM
Minsud Announces Closing of Non-Brokered Private Placement for Gross Proceeds of $944,900Minsud Announces Closing of Non-Brokered Private Placement for Gross Proceeds of $944,900
globenewswire.com - November 29 at 6:19 PM
FILO MINING ANNOUNCES POSITIVE PEA FOR FILO DEL SOL WITH A US$705 MILLION NPV AND 23% IRRFILO MINING ANNOUNCES POSITIVE PEA FOR FILO DEL SOL WITH A US$705 MILLION NPV AND 23% IRR
globenewswire.com - November 28 at 5:57 PM
Baader Bank Analysts Give Capital Stage AG (CAP) a €7.80 Price TargetBaader Bank Analysts Give Capital Stage AG (CAP) a €7.80 Price Target
www.americanbankingnews.com - November 22 at 8:17 AM
Capital Stage AG (CAP) Given a €8.50 Price Target at Warburg ResearchCapital Stage AG (CAP) Given a €8.50 Price Target at Warburg Research
www.americanbankingnews.com - November 21 at 9:24 AM
Novartis International AG: Novartis highlights its differentiated late stage pipeline at the R&D update and investor eventNovartis International AG: Novartis highlights its differentiated late stage pipeline at the R&D update and investor event
www.finanznachrichten.de - November 13 at 11:55 PM
Capital Stage AG (CAP) PT Set at €7.80 by Baader BankCapital Stage AG (CAP) PT Set at €7.80 by Baader Bank
www.americanbankingnews.com - November 10 at 6:58 AM
Strong Fiscal Year Lays the Foundation for Further Growth at OsramStrong Fiscal Year Lays the Foundation for Further Growth at Osram
www.businesswire.com - November 6 at 11:10 PM
Warburg Research Reiterates €8.50 Price Target for Capital Stage AG (CAP)Warburg Research Reiterates €8.50 Price Target for Capital Stage AG (CAP)
www.americanbankingnews.com - November 3 at 12:10 PM
UBS Group AGs (UBS) CEO Sergio Ermotti on Q3 2017 Results - Earnings Call TranscriptUBS Group AG's (UBS) CEO Sergio Ermotti on Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - October 27 at 7:28 PM
Barclays shares slump on investment bank weaknessBarclays shares slump on investment bank weakness
www.marketwatch.com - October 27 at 3:15 AM
Capital Stage AG (CAP) PT Set at €8.50 by Berenberg BankCapital Stage AG (CAP) PT Set at €8.50 by Berenberg Bank
www.americanbankingnews.com - September 13 at 6:14 AM
Warburg Research Analysts Give Capital Stage AG (CAP) a €8.50 Price TargetWarburg Research Analysts Give Capital Stage AG (CAP) a €8.50 Price Target
www.americanbankingnews.com - September 7 at 10:20 AM
Berenberg Bank Analysts Give Capital Stage AG (CAP) a €8.50 Price TargetBerenberg Bank Analysts Give Capital Stage AG (CAP) a €8.50 Price Target
www.americanbankingnews.com - September 4 at 8:44 AM
Oddo Bhf Analysts Give Capital Stage AG (CAP) a €7.15 Price TargetOddo Bhf Analysts Give Capital Stage AG (CAP) a €7.15 Price Target
www.americanbankingnews.com - September 4 at 6:56 AM
Capital Stage AG (CAP) Receives "Buy" Rating from DZ Bank AGCapital Stage AG (CAP) Receives "Buy" Rating from DZ Bank AG
www.americanbankingnews.com - August 24 at 12:44 PM
Baader Bank Reiterates €7.80 Price Target for Capital Stage AG (ETR:CAP)Baader Bank Reiterates €7.80 Price Target for Capital Stage AG (ETR:CAP)
www.americanbankingnews.com - August 3 at 8:56 AM

SEC Filings

Capital Stage (ETR:CAP) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Social activity is not available for this stock.

Financials

Financials are not available for this stock.

Chart

Capital Stage (ETR CAP) Stock Chart for Wednesday, February, 21, 2018

Loading chart…

This page was last updated on 2/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.